SKINVIVE by JUVÉDERM, a hyaluronic acid filler, has gained FDA clearance for treatment of neck lines—a new indication that expands the addressable market beyond the face. The product is formulated with JUVÉDERM's proprietary cross-linking technology and is designed for superficial dermal placement to improve skin quality and fine lines in the neck and décolletage region.
Injectables
SKINVIVE Neck-Line Indication Expands Filler Market
FDA-approved JUVÉDERM product now marketed for neck lines, opening new treatment area.
Neck/décolletage aesthetics represent a high-margin, under-penetrated treatment area.
This indication matters because neck/décolletage aesthetics represent a high-margin, under-penetrated treatment area in most practices. Patients seeking facial rejuvenation often neglect the neck, creating an upsell opportunity. The approval also positions JUVÉDERM against Restylane and Belotero in the neck-specific filler category, where clinical data supporting safety and longevity remain sparse. Practices should train injectors on placement depth and volume to avoid Tyndall effect and ensure patient satisfaction.
Source: original report ↗
Frequently asked questions
Is SKINVIVE by JUVÉDERM FDA approved for neck lines?
Yes, SKINVIVE by JUVÉDERM has received FDA clearance for treatment of neck lines and the décolletage region. It is a hyaluronic acid filler formulated with JUVÉDERM's proprietary cross-linking technology designed for superficial dermal placement to improve skin quality and fine lines in these areas.
What is the difference between SKINVIVE and other neck fillers like Restylane?
SKINVIVE uses JUVÉDERM's proprietary cross-linking technology and is specifically formulated for superficial dermal placement in the neck and décolletage. While Restylane and Belotero also treat neck lines, clinical data supporting safety and longevity across all neck-specific fillers remains limited, making proper injector training on placement depth critical.
How deep should SKINVIVE be injected in the neck?
SKINVIVE is designed for superficial dermal placement in the neck and décolletage region. Injectors must be trained on proper placement depth and volume to avoid the Tyndall effect—a bluish discoloration that occurs when filler is placed too superficially—and to ensure optimal patient satisfaction.
Is neck filler treatment a profitable service for med spas?
Yes, neck and décolletage aesthetics represent a high-margin, under-penetrated treatment area in most practices. Patients seeking facial rejuvenation often neglect the neck, making it a strong upsell opportunity to expand revenue per patient.
What are the risks of injecting filler in the neck?
The primary risk with superficial neck filler placement is the Tyndall effect, which causes visible bluish discoloration. Proper injector training on placement depth and volume is essential to avoid this complication and ensure patient satisfaction with results.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.